161 related articles for article (PubMed ID: 18470636)
21. Empty capsids in column-purified recombinant adenovirus preparations.
Vellekamp G; Porter FW; Sutjipto S; Cutler C; Bondoc L; Liu YH; Wylie D; Cannon-Carlson S; Tang JT; Frei A; Voloch M; Zhuang S
Hum Gene Ther; 2001 Oct; 12(15):1923-36. PubMed ID: 11589834
[TBL] [Abstract][Full Text] [Related]
22. Development and optimization of an adenovirus production process.
Kamen A; Henry O
J Gene Med; 2004 Feb; 6 Suppl 1():S184-92. PubMed ID: 14978761
[TBL] [Abstract][Full Text] [Related]
23. Overview of current scalable methods for purification of viral vectors.
Segura MM; Kamen AA; Garnier A
Methods Mol Biol; 2011; 737():89-116. PubMed ID: 21590394
[TBL] [Abstract][Full Text] [Related]
24. Quantifying the titer and quality of adenovirus stocks.
Wang F; Mathis BC; Montalvo A; Wolf JJ; Lewis JA
Methods Mol Biol; 2008; 434():25-36. PubMed ID: 18470637
[TBL] [Abstract][Full Text] [Related]
25. Tangential flow microfiltration and ultrafiltration for human influenza A virus concentration and purification.
Wickramasinghe SR; Kalbfuss B; Zimmermann A; Thom V; Reichl U
Biotechnol Bioeng; 2005 Oct; 92(2):199-208. PubMed ID: 16041807
[TBL] [Abstract][Full Text] [Related]
26. Purification of infectious adenovirus in two hours by ultracentrifugation and tangential flow filtration.
Ugai H; Yamasaki T; Hirose M; Inabe K; Kujime Y; Terashima M; Liu B; Tang H; Zhao M; Murata T; Kimura M; Pan J; Obata Y; Hamada H; Yokoyama KK
Biochem Biophys Res Commun; 2005 Jun; 331(4):1053-60. PubMed ID: 15882984
[TBL] [Abstract][Full Text] [Related]
27. A new scalable method for the purification of recombinant adenovirus vectors.
Green AP; Huang JJ; Scott MO; Kierstead TD; Beaupré I; Gao GP; Wilson JM
Hum Gene Ther; 2002 Nov; 13(16):1921-34. PubMed ID: 12427304
[TBL] [Abstract][Full Text] [Related]
28. Primary recovery and chromatographic purification of adeno-associated virus type 2 produced by baculovirus/insect cell system.
Chahal PS; Aucoin MG; Kamen A
J Virol Methods; 2007 Jan; 139(1):61-70. PubMed ID: 17055590
[TBL] [Abstract][Full Text] [Related]
29. Using QPCR to assign infectious potencies to adenovirus based vaccines and vectors for gene therapy: toward a universal method for the facile quantitation of virus and vector potency.
Wang F; Puddy AC; Mathis BC; Montalvo AG; Louis AA; McMackin JL; Xu J; Zhang Y; Tan CY; Schofield TL; Wolf JJ; Lewis JA
Vaccine; 2005 Aug; 23(36):4500-8. PubMed ID: 16002190
[TBL] [Abstract][Full Text] [Related]
30. A novel purification strategy for retrovirus gene therapy vectors using heparin affinity chromatography.
Segura MM; Kamen A; Trudel P; Garnier A
Biotechnol Bioeng; 2005 May; 90(4):391-404. PubMed ID: 15812800
[TBL] [Abstract][Full Text] [Related]
31. Purification of anatid herpesvirus 1 particles by tangential-flow ultrafiltration and sucrose gradient ultracentrifugation.
Guo Y; Cheng A; Wang M; Zhou Y
J Virol Methods; 2009 Oct; 161(1):1-6. PubMed ID: 19152808
[TBL] [Abstract][Full Text] [Related]
32. Characterizing clearance of helper adenovirus by a clinical rAAV1 manufacturing process.
Thorne BA; Quigley P; Nichols G; Moore C; Pastor E; Price D; Ament JW; Takeya RK; Peluso RW
Biologicals; 2008 Jan; 36(1):7-18. PubMed ID: 17644406
[TBL] [Abstract][Full Text] [Related]
33. Purification of plasmid DNA using tangential flow filtration and tandem anion-exchange membrane chromatography.
Guerrero-Germán P; Prazeres DM; Guzmán R; Montesinos-Cisneros RM; Tejeda-Mansir A
Bioprocess Biosyst Eng; 2009 Aug; 32(5):615-23. PubMed ID: 19083017
[TBL] [Abstract][Full Text] [Related]
34. Methods for the production of helper-dependent adenoviral vectors.
Palmer DJ; Ng P
Methods Mol Biol; 2008; 433():33-53. PubMed ID: 18679616
[TBL] [Abstract][Full Text] [Related]
35. Effect of re-feed strategies and non-ammoniagenic medium on adenovirus production at high cell densities.
Ferreira TB; Ferreira AL; Carrondo MJ; Alves PM
J Biotechnol; 2005 Sep; 119(3):272-80. PubMed ID: 15885836
[TBL] [Abstract][Full Text] [Related]
36. Production of first generation adenoviral vectors for preclinical protocols: amplification, purification and functional titration.
Armendáriz-Borunda J; Bastidas-Ramírez BE; Sandoval-Rodríguez A; González-Cuevas J; Gómez-Meda B; García-Bañuelos J
J Biosci Bioeng; 2011 Nov; 112(5):415-21. PubMed ID: 21856222
[TBL] [Abstract][Full Text] [Related]
37. An efficient process for the purification of helper-dependent adenoviral vector and removal of helper virus by iodixanol ultracentrifugation.
Dormond E; Chahal P; Bernier A; Tran R; Perrier M; Kamen A
J Virol Methods; 2010 Apr; 165(1):83-9. PubMed ID: 20116403
[TBL] [Abstract][Full Text] [Related]
38. Sorption processes in ion-exchange chromatography of viruses.
Trilisky EI; Lenhoff AM
J Chromatogr A; 2007 Feb; 1142(1):2-12. PubMed ID: 17240385
[TBL] [Abstract][Full Text] [Related]
39. Purification of recombinant adenovirus type 3 dodecahedric virus-like particles for biomedical applications using short monolithic columns.
Urbas L; Jarc BL; Barut M; Zochowska M; Chroboczek J; Pihlar B; Szolajska E
J Chromatogr A; 2011 Apr; 1218(17):2451-9. PubMed ID: 21295784
[TBL] [Abstract][Full Text] [Related]
40. Electrophysiological studies of ion channels and therapeutic potential with adenovirus-mediated gene transfer.
Qu J; Pham TV; Obreztchikova MN
Methods Mol Biol; 2003; 227():179-212. PubMed ID: 12824650
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
